“…In addition to auxiliary proteins and lipid cofactors, different small-molecule modulators of KCNQ1 have been reported in the literature. Zinc pyrithione (19) and L-364,373 (R-L3) (20) activate homomeric KCNQ1 channels, mefenamic acid (21), 4,4’-diisothiocyano-2,2’-stilbenedisulfonic acid (22), and rottlerin (23) activate the KCNQ1-KCNE1 complex, and phenylboronic acid (24), hexachlorophene (25), and 3-ethyl-2-hydroxy-2-cyclopenten-1-one (26) potentiate both KCNQ1 and KCNQ1-KCNE1. While some of these activators are able to shorten the action potential duration in isolated cardiac myocytes (20, 25), they have low potency and are not selective against other members of the KCNQ family or the hERG potassium channel.…”